Fingerprint
Dive into the research topics of 'Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: Phase II results from the north central cancer treatment group (N044B)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically